Associates of Cape Cod, Inc. Expands Glycobiology Product Division

East Foulmouth, MA - Associates of Cape Cod, Inc. (ACC), a leading manufacturer of endotoxin and beta-glucan detection products and a major supplier to the pharmaceutical and medical device industries, recently announced that it has expanded its glycobiology research product line to include reagents from the most innovative manufacturers in the industry. These manufacturers specialize in carbohydrate chemistry, glycoprofiling and glycobiology and glycosaminoglycan (GAG) enzymes and, through new distribution partnerships with ACC, will offer a wide range of unique products.

To support this expansion, ACC has created a new brand for its distributed products line, Northstar BioProducts™. In addition, the Seikagaku America product line has been merged into this new division, and will continue to be offered as one of the many unique brands under Northstar BioProducts™. ACC expects to launch additional products in the near future, and will make separate announcements for each.

"Associates of Cape Cod, Inc. is aggressively expanding our offerings to include high quality products that are synergistic with the Seikagaku Corporation glycobiology product line to serve the growing needs of our customers and distributors. We continue to focus primarily on products related to glycobiology and carbohydrate biochemistry, and have added new products from suppliers who share our product portfolio strategy and vision," said President and Chief Executive Officer of ACC, Dr. A.J. Meuse. He continued, "This further illustrates our commitment to delivering the highest quality products to continue to satisfy our customer's expectations."

Click Here to Download

SOURCE: Associates Of Cape Cod